08.02.19
Manatt’s Patricia Boozang, a senior managing director with Manatt Health, spoke with Bloomberg Law on new ballot initiatives in five states to expand Medicaid.
07.31.19
Manatt’s Ian Spatz, a senior advisor with Manatt Health, spoke with Inside Health Policy on the Trump administration’s newly announced two-track plan to allow drug importation.
07.26.19
Manatt’s Ian Spatz, senior advisor with Manatt Health, spoke with BioCentury about new drug pricing legislation in Congress.
07.11.19
Manatt’s Ian Spatz, a senior advisor with Manatt Health, spoke with FierceHealthcare on the Trump administration’s withdrawal of its plan to eliminate legal protections for drug rebates in Medicare Part D.
07.10.19
Manatt’s Ian Spatz, a senior advisor with Manatt Health, spoke with The Hill on a recent federal court ruling concerning drug price disclosures in TV ads.
Manatt’s Ian Spatz, a senior advisor with Manatt Health, spoke with Pink Sheet on a recent federal court ruling concerning drug prices in TV ads.
07.09.19
Manatt’s Ian Spatz, a senior advisor with Manatt Health, spoke with InsideHealthPolicy on a federal court’s decision to block the Trump administration’s proposed rule to include drug prices in television ads for prescription drugs.
06.18.19
Manatt’s Jocelyn Guyer, managing director with Manatt Health, spoke with FierceHealthcare about a new report on CHIP and Medicaid, and their impact on the social and emotional well-being of children.
06.15.19
Cindy Mann, a partner with Manatt Health, spoke to POLITICO about California’s upcoming health care expansion that will extend full Medicaid benefits to undocumented young people.
06.14.19
Manatt’s Michael Kolber, a partner with Manatt Health, spoke with FierceHealthcare on the Trump administration’s expansion of health reimbursement arrangements.